PowerVerde regains rights to patented molecule Propofol Hemisuccinate
M2 - Fri Jul 31, 6:44AM CDT
PowerVerde (OTCBB
PowerVerde Inc. Announces the Reacquisition of Patented Molecule
PRWeb - Fri Jul 31, 5:02AM CDT
PowerVerde Inc. (OTCBB-PWVI) a developer of renewable thermal powered electricity generator systems, today announced that it has reacquired the rights to a patented molecule known as Propofol Hemisuccinate. This intellectual property (IP) was previously sold by PowerVerde at the time of its 2008 reverse merger with Vyrex Corporation. "The opportunity to repurchase the complete patent, as well as an existing licensing agreement with a private company, complements our IP portfolio strategy, which helps to provide funding for our renewable power systems core business," said CEO Rick Davis.